High Tech Pharm Co. Ltd (KQ:106190) — Market Cap & Net Worth
Market Cap & Net Worth: High Tech Pharm Co. Ltd (106190)
High Tech Pharm Co. Ltd (KQ:106190) has a market capitalization of $74.58 Million (₩110.05 Billion) as of September 17, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #20427 globally and #1115 in its home market, demonstrating a -0.86% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying High Tech Pharm Co. Ltd's stock price ₩10350.00 by its total outstanding shares 10632598 (10.63 Million). Also see High Tech Pharm Co. Ltd assets under control for a full breakdown of the balance sheet.
High Tech Pharm Co. Ltd Market Cap History: 2015 to 2026
High Tech Pharm Co. Ltd's market capitalization history from 2015 to 2026. Data shows growth from $67.14 Million to $74.58 Million (1.07% CAGR). Also see High Tech Pharm Co. Ltd operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
High Tech Pharm Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$231.82 Billion | 0.03% | #490 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$231.82 Billion | 0.03% | #490 of 1384 |
Weight: High Tech Pharm Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
High Tech Pharm Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how High Tech Pharm Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 106190 stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
High Tech Pharm Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
High Tech Pharm Co. Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $67.14 Million | $48.09 Billion | $6.54 Billion | 0.00x | 0.01x |
| 2016 | $68.99 Million | $54.84 Billion | $5.28 Billion | 0.00x | 0.01x |
| 2017 | $55.13 Million | $66.05 Billion | $2.10 Billion | 0.00x | 0.03x |
| 2018 | $81.53 Million | $66.39 Billion | $2.61 Billion | 0.00x | 0.03x |
| 2019 | $53.19 Million | $63.07 Billion | -$4.22 Billion | 0.00x | N/A |
| 2020 | $87.11 Million | $74.46 Billion | -$3.15 Billion | 0.00x | N/A |
| 2021 | $64.92 Million | $73.29 Billion | -$1.23 Billion | 0.00x | N/A |
| 2022 | $51.98 Million | $102.95 Billion | $5.87 Billion | 0.00x | 0.01x |
| 2023 | $67.23 Million | $76.77 Billion | $8.08 Billion | 0.00x | 0.01x |
| 2024 | $100.88 Million | $77.51 Billion | $13.71 Billion | 0.00x | 0.01x |
Competitor Companies of 106190 by Market Capitalization
Companies near High Tech Pharm Co. Ltd in the global market cap rankings as of September 17, 2026. Review tangible net worth ratio of High Tech Pharm Co. Ltd to assess the quality of the company's equity after excluding intangible assets.
Key companies related to High Tech Pharm Co. Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
High Tech Pharm Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, High Tech Pharm Co. Ltd's market cap moved from $67.14 Million to $ 74.58 Million, with a yearly change of 1.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩74.58 Million | -13.89% |
| 2025 | ₩86.61 Million | -14.14% |
| 2024 | ₩100.88 Million | +50.05% |
| 2023 | ₩67.23 Million | +29.33% |
| 2022 | ₩51.98 Million | -19.93% |
| 2021 | ₩64.92 Million | -25.47% |
| 2020 | ₩87.11 Million | +63.78% |
| 2019 | ₩53.19 Million | -34.76% |
| 2018 | ₩81.53 Million | +47.89% |
| 2017 | ₩55.13 Million | -20.09% |
| 2016 | ₩68.99 Million | +2.75% |
| 2015 | ₩67.14 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of High Tech Pharm Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $74.58 Million USD |
| MoneyControl | $74.58 Million USD |
| MarketWatch | $74.58 Million USD |
| marketcap.company | $74.58 Million USD |
| Reuters | $74.58 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About High Tech Pharm Co. Ltd
High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.